2-hydroxyestradiol

2-hydroxyestradiol is a lipid of Sterol Lipids (ST) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 1446 references associated with 2-hydroxyestradiol in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

Here are additional resources we collected from PubChem and MeSH for 2-hydroxyestradiol

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 2-hydroxyestradiol

MeSH term MeSH ID Detail
Kidney Neoplasms D007680 29 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Cell Transformation, Neoplastic D002471 126 associated lipids
Neoplasms, Hormone-Dependent D009376 23 associated lipids
Total 4

PubChem Biomolecular Interactions and Pathways

NCBI Entrez Crosslinks

All references with 2-hydroxyestradiol

Download all related citations
Per page 10 20 50 100 | Total 345
Authors Title Published Journal PubMed Link
Gao W et al. Serum concentrations of selected endogenous estrogen and estrogen metabolites in pre- and post-menopausal Chinese women with osteoarthritis. 2010 J. Endocrinol. Invest. pmid:20339312
Yusuf R and Frenkel K Morphologic transformation of human breast epithelial cells MCF-10A: dependence on an oxidative microenvironment and estrogen/epidermal growth factor receptors. 2010 Cancer Cell Int. pmid:20809984
Dubey RK et al. Resveratrol, a red wine constituent, blocks the antimitogenic effects of estradiol on human female coronary artery smooth muscle cells. 2010 J. Clin. Endocrinol. Metab. pmid:20534756
Chen MH et al. Involvement of CFTR in oviductal HCO3- secretion and its effect on soluble adenylate cyclase-dependent early embryo development. 2010 Hum. Reprod. pmid:20406739
Singh B et al. Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats. 2010 Toxicol. Appl. Pharmacol. pmid:20600213
Fleming JM et al. The normal breast microenvironment of premenopausal women differentially influences the behavior of breast cancer cells in vitro and in vivo. 2010 BMC Med pmid:20492690
Taioli E et al. Comparison of estrogens and estrogen metabolites in human breast tissue and urine. 2010 Reprod. Biol. Endocrinol. pmid:20678202
Hill BJ et al. Nongenomic inhibition of coronary constriction by 17ß-estradiol, 2-hydroxyestradiol, and 2-methoxyestradiol. 2010 Can. J. Physiol. Pharmacol. pmid:20237589
Kang KS et al. Dual beneficial effects of (-)-epigallocatechin-3-gallate on levodopa methylation and hippocampal neurodegeneration: in vitro and in vivo studies. 2010 PLoS ONE pmid:20700524
Takemura H et al. A methoxyflavonoid, chrysoeriol, selectively inhibits the formation of a carcinogenic estrogen metabolite in MCF-7 breast cancer cells. 2010 J. Steroid Biochem. Mol. Biol. pmid:19833205